Reports and Insight

Pharma Futures 3: Emerging Opportunities (2009) explores the link between sustainable pharmaceutical business models and global health outcomes in emerging markets.

Pharma Futures: Prescription for Long-Term Value (2007) outlines the findings of a twelve month facilitated dialogue between leading industry executives and major institutional investors on how the sector can better deliver long-term value to shareholders and consumers.

Pharma Futures 1: A Long-Term Value Outlook (2004) presents the findings of the Pharma Futures scenario planning project. The report is sponsored by three major pension funds – ABP (Netherlands), the Ohio Public Employees Retirement System (OPERS, US), and the Universities Superannuation Scheme (USS, UK).